| |
Company
Roster
|
|
Total
Insiders : |
55 |
|
|
|
Total
Direct Shares :
|
4,109,324 |
|
|
Total
Indirect Shares :
|
41,127,049 |
| |
%
Held by Insiders:
|
8.35% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Hughes Owen |
Director |
2022-08-15 |
0 |
2019-02-13 |
0 |
| Garnier Jean Pierre |
Director |
2022-08-15 |
0 |
2019-02-13 |
0 |
| Murphy Sean |
Director |
2022-08-15 |
0 |
2021-02-22 |
0 |
| Von Eschenbach Andrew C. |
Director |
2022-08-15 |
0 |
2022-01-14 |
0 |
| Messersmith Elizabeth |
Senior Vice President |
2022-08-15 |
0 |
|
0 |
| Dere Willard H |
Director |
2022-08-15 |
0 |
2019-02-13 |
0 |
| Holtschlag Danielle |
Vice President, Sales |
2022-08-15 |
0 |
2022-01-14 |
0 |
| Shah Chhaya |
Chief Business Officer |
2022-08-15 |
0 |
|
0 |
| Martin G. Kelly |
CEO and President, Director |
2022-08-15 |
0 |
2022-02-21 |
0 |
| Friedman Cathy |
Director |
2022-08-15 |
0 |
2019-02-13 |
0 |
| Sanders Machelle |
Director |
2022-08-15 |
0 |
2022-01-14 |
0 |
| Bb Biotech Ag |
10% Owner |
2022-08-11 |
0 |
2014-06-06 |
0 |
| Conley Mark William |
VP, Chief Financial Officer |
2022-03-15 |
50,000 |
2022-03-15 |
0 |
| Helwig Steven |
Principal Financial Officer |
2022-01-14 |
31,251 |
2021-08-24 |
0 |
| Rosen David Efraim |
10% Owner |
2021-12-08 |
0 |
2022-08-11 |
8,642,271 |
| Chopas James George |
Principal Finance Accounting |
2021-03-05 |
6,701 |
|
0 |
| Grausso Sal |
Chief Commercial Officer |
2021-02-25 |
11,709 |
2021-02-25 |
0 |
| Carmona Jose |
Chief Financial Officer |
2020-02-26 |
46,708 |
2017-09-14 |
0 |
| Rosenberg Anthony |
Director |
2020-02-26 |
12,401 |
2019-02-13 |
0 |
| Kelly Joseph Francis |
Sr. VP of Sales and Marketing |
2020-02-26 |
24,111 |
2018-12-17 |
0 |
| Morris Charles Q |
Chief Medical Officer |
2020-02-26 |
33,744 |
2019-02-22 |
0 |
| Hopfield Jessica |
Director |
2020-02-20 |
18,300 |
2019-03-05 |
0 |
| Graves Kurt |
Director |
2020-02-20 |
11,000 |
2015-06-18 |
0 |
| Roychowdhury Debasish |
Director |
2019-04-11 |
5,500 |
2019-02-13 |
0 |
| Hatzis-Schoch Brent |
Sr. VP, General Counsel |
2019-02-22 |
17,944 |
|
0 |
| Hoiland Jesper |
President and CEO, Director |
2017-11-07 |
12,900 |
2017-09-15 |
0 |
| Harvey Brian Nicholas |
Sr. VP and CFO |
2017-04-25 |
76,189 |
2011-05-17 |
0 |
| Ward Robert |
President & CEO, Director |
2016-10-25 |
15,000 |
2015-06-04 |
0 |
| Steinmetz Michael |
Former 10% stockholder |
2016-09-27 |
0 |
2016-09-27 |
2,459,804 |
| Foley Todd |
Former 10% stockholder |
2016-09-27 |
0 |
2016-09-27 |
1,427,698 |
| Fitzpatrick Lorraine A. |
Chief Medical Officer |
2016-01-25 |
200 |
2016-01-25 |
0 |
| Hattersley Gary |
Chief Scientific Officer |
2015-11-12 |
0 |
2015-10-21 |
0 |
| Ward Rob |
President & CEO, Director |
2015-10-21 |
0 |
2015-10-21 |
0 |
| Snow David P. |
Chief Commercial Officer |
2015-09-14 |
6,000 |
2015-09-14 |
0 |
| Purandare Dinesh |
SVP Global Oncology/Commercial |
2015-08-31 |
200 |
2015-08-31 |
0 |
| Globeways Holdings Ltd |
10% Owner |
2015-01-16 |
0 |
2015-01-16 |
0 |
| Priestley Katherine |
10% Owner |
2015-01-08 |
1,167,997 |
2014-06-06 |
0 |
| F2 Bioscience Iv Gp Ltd. |
10% Owner |
2014-06-11 |
587,500 |
|
0 |
| F2 Bioscience Vi L.p. |
10% Owner |
2014-06-11 |
1,794,983 |
2014-06-11 |
587,500 |
| Muenchbach Martin |
Director |
2014-06-06 |
0 |
2014-06-11 |
1,393,443 |
| Kailian Vaughn M |
10% Owner |
2014-06-06 |
0 |
2014-06-06 |
2,141,547 |
| Wheeler Kurt |
Former 10% stockholder |
2014-06-06 |
0 |
2016-09-27 |
2,459,804 |
| Jovan-Embiricos Morana |
Director, 10% Owner |
2014-06-06 |
0 |
2015-01-08 |
3,834,831 |
| Mpm Bioventures III Qp Lp |
10% Owner |
2014-06-06 |
0 |
2014-06-06 |
3,689,706 |
| Brookside Capital Partners Fund Lp |
10% Owner |
2014-06-05 |
0 |
2014-06-05 |
1,943,241 |
| Lyttle Cecil Richard |
Officer |
2013-11-26 |
66,666 |
2011-05-17 |
0 |
| Odea Louis |
Sr VP, Chief Medical Officer |
2011-05-17 |
29,207 |
2011-05-17 |
0 |
| Cavanaugh James H |
10% Owner |
2011-05-17 |
83,113 |
|
0 |
| Fleming Jonathan |
Director |
2011-05-17 |
0 |
2011-05-17 |
15,324 |
| Gadicke Ansbert |
Director |
|
0 |
2016-09-27 |
3,887,502 |
| Yates John |
|
|
0 |
|
0 |
| Evnin Luke |
Former 10% stockholder |
|
0 |
2016-09-27 |
3,887,502 |
| Nordic Bioscience Clinical Development Vii A/s |
|
|
0 |
|
0 |
| Williams Gregory C. |
|
|
0 |
|
0 |
| Rubric Capital Management Lp |
10% Owner |
|
0 |
2021-12-08 |
4,756,876 |
|
